Cincinnati Children’s Stands at the Ready to Help With the Search for Treatments and a Vaccine
Wednesday, March 18, 2020
The Vaccine Treatment and Evaluation Unit (VTEU) at Emory University has been activated to join a 20-site National Institutes of Health clinical trial to evaluate novel therapies for people hospitalized by COVID-19. Read full announcement.
There are nine VTEUs nationwide, including one based at Cincinnati Children’s, which has a long history of vaccine research. They’re all part of the Infectious Diseases Clinical Research Consortium, which was formed in 2019 to support the planning and implementation of infectious diseases clinical research.
So far, the VTEU at Cincinnati Children’s has not been activated, says Paul Spearman, MD, Director, Division of Infectious Diseases here, but teams here are getting ready.
“Yes, we are preparing for this trial. Bob Frenck and I have taken the lead on this, and hope to work with many others locally,” Spearman says. “We are planning to partner with the University of Cincinnati in order to offer infected adults access to the clinical trial. However we are not yet activated as a site.”
All Cincinnati Children's Coronavirus (COVID-19) Resources